An investigator-sponsored study of LB1148 for the treatment of severe shock.
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Shock
- Focus Therapeutic Use
- 31 Aug 2016 New trial record
- 10 Aug 2016 According to a Leading BioSciences media release, this trial is planned for the third quarter of 2016.